Loading clinical trials...

RECRUITINGNCT05597410

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

The goal of this cohort study is to estimate the incidence of AD in the first-degree relatives of patients with AD. The main questions it aims to answer are: * cognitive changes of subjects at high r...

Lead sponsor: Ruijin Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Gang Wang, MD, PhD

CONTACT

086-021-64370045 wg11424@rjh.com.cn

Related studies

RECRUITINGPhase 3

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

NCT07571161 · Alzheimer Disease

RECRUITINGPhase 2

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

NCT06847321 · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis

RECRUITINGPhase 3

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

NCT06937229 · Alzheimer Disease, Agitation

RECRUITING

Clinical Procedures to Support Research in ALS

NCT03489278 · Amyotrophic Lateral Sclerosis, ALS-Frontotemporal Dementia, and more

RECRUITINGPhase 4

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

NCT07633470 · Alzheimer Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 28, 2022Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment3,418

Start dateMar 2022

Last updatedOct 28, 2022

Condition

Alzheimer Disease Dementia Neurodegenerative Diseases Cognitive Impairment Neurocognitive Disorders

Locations shown

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 28, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions